Patients with a visit between January 1, 2019 and February 29, 2020 | Patients with COVID-19b (March 1, 2020 to October 10, 2020) | ||||
---|---|---|---|---|---|
No. patients | % patients with pre-existing conditionsa by February 29, 2020 | No. patients | % patients with pre-existing conditionsa by October 10, 2020 | % patients without pre-existing conditionsa by October 10, 2020 | |
All patients | 784,332 | 61% | 7532 | 67% | 33% |
Hispanic | 248,942 | 55% | 4391 | 64% | 36% |
Non-Hispanic Asian | 30,684 | 44% | 244 | 49% | 51% |
Non-Hispanic black | 138,875 | 60% | 1474 | 72% | 28% |
Non-Hispanic other | 13,466 | 68% | 72 | 79% | 21% |
Non-Hispanic white | 285,175 | 71% | 1004 | 78% | 22% |
Unknown | 67,190 | 55% | 347 | 63% | 37% |
↵a Pre-existing conditions include HIV/AIDS; lupus; alcohol and drug abuse (excludes tobacco use); mental disorders (eg, depression, bipolar disorder); Alzheimer's/dementia; multiple sclerosis; rheumatoid arthritis, fibromyalgia and other inflammatory joint diseases; muscular dystrophy; cancer other than skin; severe obesity; cerebral palsy; congestive heart failure; paraplegia and paralysis; coronary artery disease; Crohn's disease and ulcerative colitis; Parkinson's disease; chronic obstructive pulmonary disease, emphysema, and asthma; diabetes mellitus; pneumocystic pneumonia; epilepsy; hemophilia; sleep apnea; hepatitis; stroke; and kidney disease/renal failure. Pre-existing conditions identified among patient with an in-person office visit between January 1, 2019 and February 29, 2020.
↵b Patients with COVID-19 are those with a positive laboratory result in their electronic health record or a COVID-19 diagnosis code.